Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Double Eagle Holdings, Ltd. (otcqb
ROP), the parent company of Fuse Science, Inc. ( www.fusescience.com ), announced today the formal launch of its Hypoglycemic, Hyperglycemic, and Analgesic project platforms for the advancement of its OTC and pharmaceutical licensing efforts.
Some of the proprietary science platforms that Fuse Science deals with are oral fuse delivery technologies (OFD's). These OFD's are placed under the tongue or in the inner cheek of the patient where they are absorbed and release the applicable active or nutrient into the blood stream. OFD's do not require water and may be more convenient to take than liquids or injections. OFD's are especially designed to be very useful with pediatric and geriatric patients or anyone in need of faster absorption of a given active into the blood stream that bypasses the GI track, providing an alternative to the more traditional invasive drug delivery systems.
http://www.marketwatch.com/story/fu...ery-ofd-research-project-platforms-2011-12-20
ROP), the parent company of Fuse Science, Inc. ( www.fusescience.com ), announced today the formal launch of its Hypoglycemic, Hyperglycemic, and Analgesic project platforms for the advancement of its OTC and pharmaceutical licensing efforts.Some of the proprietary science platforms that Fuse Science deals with are oral fuse delivery technologies (OFD's). These OFD's are placed under the tongue or in the inner cheek of the patient where they are absorbed and release the applicable active or nutrient into the blood stream. OFD's do not require water and may be more convenient to take than liquids or injections. OFD's are especially designed to be very useful with pediatric and geriatric patients or anyone in need of faster absorption of a given active into the blood stream that bypasses the GI track, providing an alternative to the more traditional invasive drug delivery systems.
http://www.marketwatch.com/story/fu...ery-ofd-research-project-platforms-2011-12-20